Tag archive for ‘ADHD’
Jewish Business News On Thursday, September 17th, 2015

Diagnostic apps for ADHD, dementia?

  A team of IBM research scientists from Haifa won the top prize at the Brain Inspired Technology for Education (BITE) Hackathon held recently at the Technion-Israel Institute of Technology in Haifa,  More...

Gali Weinreb On Sunday, January 11th, 2015

ADHD treatment co Alcobra raises $26 million on Nasdaq

– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial.   Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD), which is developing a drug for More...

Michael Ordman On Sunday, November 2nd, 2014

The weekly good news from Israel

– In the 2nd Nov 2014 edition of Israel’s good news, the highlights include:   ·        Israel’s Universal Flu Vaccine is granted international patents. ·        The United More...

Michael Ordman On Sunday, August 31st, 2014

Quadriplegics Will Stand Up and Many More Good News from Israel

Israel’s Good News for Aug 31st 2014 ISRAEL’S MEDICAL ACHIEVEMENTS   A foolproof method for diagnosing ADHD.  Scientists at Tel Aviv University, Sheba Medical Center and Haifa University have discovered More...

Globes On Sunday, October 27th, 2013

Alcobra Raises $33 Million In Secondary Nasdaq Offering

– The ADHD treatment developer raised $27 million in its IPO in May. –     Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million in its secondary offering on Thursday. More...

Research: A Single Dose of ADHD Drug Can Reduce Fall Risk Among Elderly Adults

– – BGU researchers have discovered that a single dose of methylphenidate (MPH), used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy, helps to improve balance control More...

Ilan Shavit On Sunday, June 9th, 2013

Shire Licenses Teva to Sell Genereic Version of INTUNIV treatment for ADHD

– /By Ilan Shavit/ Pharmaceutical company Shire LLC announced on May 31st it has settled its litigation against Israeli company Teva Pharmaceutical’s US subsidiary, Teva Pharmaceuticals USA Inc., More...

Contributor On Thursday, May 23rd, 2013

ADHD co Alcobra raises $25 million on Nasdaq

– Alcobra held the IPO at $8 per share, raising $25 million, at a company value of $89 million, lower than the $10-12 per share it had hoped for. /Tali Tsipori and Gali Weinreb, Globes/ Alcobra More...

Wordpress site Developed by Fixing WordPress Problems